1. Tappeh K, Mohammadzadeh H, Khashaveh S, Rezapour B. Prevalence of intestinal parasitic infections among primary school students in Barandooz-Chay rural region of Urmia, 2007. Urmia Med J. 2010; 21(3):237-42.
2. Daryani A, Sarvi S, Aarabi M, Mizani A, Ahmadpour E, Shokri A, et al. Seroprevalence of Toxoplasma gondii in the Iranian general population: A systematic review and meta-analysis. Acta trop. 2014;137:185-94.
3. Gharavi M, Rahnama N, Jahani M. Seroepidemiological survey of Toxoplasma infections of mentally retarded children. Iran J Public Health. 2005; 34(1):19-22.
4. Torda A. Toxoplasmosis: are cats really the source?. Aust Fam Physician. 2001; 30(8):743.
5. Gharavi M, Jalali S, Khademvatan S, Heydari S. Detection of IgM and IgG anti-Toxoplasma antibodies in renal transplant recipients using ELFA, ELISA and ISAGA methods: comparison of pre-and post-transplantation status. Ann Trop Med Parasitol. 2011; 105(5):367-71.
6. Soltani S, Khademvatan S, Saki J, Shahbazian H. Detection of Toxoplasmosis in Renal Transplant Recipients by ELISA and PCR Methods in Ahvaz, South-West of Iran. Jundishapur J Microbiol. 2013; 6(9):1-5. doi:10.5812/jjm.7642
7. Maraghi S, Yadyad MJ, Sheikhi M, Shamakhteh F, Latifi SM. Study the anti-Toxoplasma antibodies (IgG and IgM) in hemodialysis patients of Abadan and Khoramshahr cities Southwest Iran in 2011 using ELISA. Jundishapur J Microbiol. 2013; 6(7):1-4. doi:10.5812/jjm.7113
8. Ocak S, Duran N, Eskiocak AF, Aytac H. Anti-Toxoplasma gondii antibodies in hemodialysis patients receiving long-term hemodialysis therapy in Turkey. Saudi Med J. 2005; 26(9):1378-82. PMID:16155651
9. Saki J, Khademvatan S, Soltani S, Shahbazian H. Detection of toxoplasmosis in patients with end-stage renal disease by enzyme-linked immunosorbent assay and polymerase chain reaction methods. Parasitol Res. 2013; 112(1):163-8.
10. Firouz ZE, Kaboosi H, Nasiri AF, Tabatabaie SS, Golhasani-Keshtan F, Zaboli F. A comparative serological study of toxoplasmosis in pregnant women by CLIA and ELISA methods in Chalus City Iran. Iran Red Crescent Med J. 2014;16(4):e15115.
doi:10.5812/ircmj.15115
11. House A. Psychosocial problems of patients on the renal unit and their relation to treatment outcome. J psychosom Res. 1987; 31(4):441-52.
12. Szepietowski JC, Reich A, Pacan P. Psychodermatoses in haemodialysis patients. Dermatol. 2004; 209(4):344-5.
doi:10.1159/000080865
13. Vonesh EF, Snyder J, Foley RN, Collins AJ. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int. 2004; 66(6):2389-401.
15. Zadeh AE, Bamedi T, Etemadi S, Shahrakipour M, Saryazdipour K. Toxoplasmosis as a complication of transfusion in hemodialysis patients. Iran J Ped Hematol Oncol. 2014; 4(1):22.
PMID: 24734160
16. Rasti S, Hassanzadeh M, Soliemani A, Hooshyar H, Mousavi SGA, Nikoueinejad H, et al. Serological and molecular survey of toxoplasmosis in renal transplant recipients and hemodialysis patients in Kashan and Qom regions, central Iran. Ren Fail. 2016; 38(6):970-3.
17. Rezavand B, Poornaki AM, Mokhtari KR, Mohammad A, Andalibian A, Abdi J. Identification and determination of the prevalence of Toxoplasma gondii in patients with chronic renal failure by ELISA and PCR. Asian Pac J Trop Dis. 2016; 6(5):347-9.
18. Abdul-Aziz AI, Zghair KH. Study of Epidemiology of Toxoplasmosis in Hemodialysis Patients in Baghdad Hospitals. Iraqi J Sci. 2014; 55: 1236-42.